Cargando…

The Role of Prostatitis in Prostate Cancer: Meta-Analysis

OBJECTIVE: Use systematic review methods to quantify the association between prostatitis and prostate cancer, under both fixed and random effects model. EVIDENCE ACQUISITION: Case control studies of prostate cancer with information on prostatitis history. All studies published between 1990-2012, wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Junyi, Li, Jinyi, Yunxia, Zhang, Zhu, Hong, Liu, Junjiang, Pumill, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877315/
https://www.ncbi.nlm.nih.gov/pubmed/24391995
http://dx.doi.org/10.1371/journal.pone.0085179
_version_ 1782297624585437184
author Jiang, Junyi
Li, Jinyi
Yunxia, Zhang
Zhu, Hong
Liu, Junjiang
Pumill, Chris
author_facet Jiang, Junyi
Li, Jinyi
Yunxia, Zhang
Zhu, Hong
Liu, Junjiang
Pumill, Chris
author_sort Jiang, Junyi
collection PubMed
description OBJECTIVE: Use systematic review methods to quantify the association between prostatitis and prostate cancer, under both fixed and random effects model. EVIDENCE ACQUISITION: Case control studies of prostate cancer with information on prostatitis history. All studies published between 1990-2012, were collected to calculate a pooled odds ratio. Selection criteria: the selection criteria are as follows: human case control studies; published from May 1990 to July 2012; containing number of prostatitis, and prostate cancer cases. EVIDENCE SYNTHESIS: In total, 20 case control studies were included. A significant association between prostatitis and prostate cancer was found, under both fixed effect model (pooled OR=1.50, 95%CI: 1.39-1.62), and random effects model (OR=1.64, 95%CI: 1.36-1.98). Personal interview based case control studies showed a high level of association (fixed effect model: pooled OR=1.59, 95%CI: 1.47-1.73, random effects model: pooled OR= 1.87, 95%CI: 1.52-2.29), compared with clinical based studies (fixed effect model: pooled OR=1.05, 95%CI: 0.86-1.28, random effects model: pooled OR= 0.98, 95%CI: 0.67-1.45). Additionally, pooled ORs, were calculated for each decade. In a fixed effect model: 1990’s: OR=1.58, 95% CI: 1.35-1.84; 2000’s: OR=1.59, 95% CI: 1.40-1.79; 2010’s: OR=1.37, 95% CI: 1.22-1.56. In a random effects model: 1990’s: OR=1.98, 95% CI: 1.08-3.62; 2000’s: OR=1.64, 95% CI: 1.23-2.19; 2010’s: OR=1.34, 95% CI: 1.03-1.73. Finally a meta-analysis stratified by each country was conducted. In fixed effect models, U.S: pooled OR =1.45, 95%CI: 1.34-1.57; China: pooled OR =4.67, 95%CI: 3.08-7.07; Cuba: pooled OR =1.43, 95%CI: 1.00-2.04; Italy: pooled OR =0.61, 95%CI: 0.13-2.90. In random effects model, U.S: pooled OR=1.50, 95%CI: 1.25-1.80; China: pooled OR =4.67, 95%CI: 3.08-7.07; Cuba: pooled OR =1.43, 95%CI: 1.00-2.04; Italy: pooled OR =0.61, 95%CI: 0.13-2.90.CONCLUSIONS: the present meta-analysis provides the statistical evidence that the association between prostatitis and prostate cancer is significant.
format Online
Article
Text
id pubmed-3877315
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38773152014-01-03 The Role of Prostatitis in Prostate Cancer: Meta-Analysis Jiang, Junyi Li, Jinyi Yunxia, Zhang Zhu, Hong Liu, Junjiang Pumill, Chris PLoS One Research Article OBJECTIVE: Use systematic review methods to quantify the association between prostatitis and prostate cancer, under both fixed and random effects model. EVIDENCE ACQUISITION: Case control studies of prostate cancer with information on prostatitis history. All studies published between 1990-2012, were collected to calculate a pooled odds ratio. Selection criteria: the selection criteria are as follows: human case control studies; published from May 1990 to July 2012; containing number of prostatitis, and prostate cancer cases. EVIDENCE SYNTHESIS: In total, 20 case control studies were included. A significant association between prostatitis and prostate cancer was found, under both fixed effect model (pooled OR=1.50, 95%CI: 1.39-1.62), and random effects model (OR=1.64, 95%CI: 1.36-1.98). Personal interview based case control studies showed a high level of association (fixed effect model: pooled OR=1.59, 95%CI: 1.47-1.73, random effects model: pooled OR= 1.87, 95%CI: 1.52-2.29), compared with clinical based studies (fixed effect model: pooled OR=1.05, 95%CI: 0.86-1.28, random effects model: pooled OR= 0.98, 95%CI: 0.67-1.45). Additionally, pooled ORs, were calculated for each decade. In a fixed effect model: 1990’s: OR=1.58, 95% CI: 1.35-1.84; 2000’s: OR=1.59, 95% CI: 1.40-1.79; 2010’s: OR=1.37, 95% CI: 1.22-1.56. In a random effects model: 1990’s: OR=1.98, 95% CI: 1.08-3.62; 2000’s: OR=1.64, 95% CI: 1.23-2.19; 2010’s: OR=1.34, 95% CI: 1.03-1.73. Finally a meta-analysis stratified by each country was conducted. In fixed effect models, U.S: pooled OR =1.45, 95%CI: 1.34-1.57; China: pooled OR =4.67, 95%CI: 3.08-7.07; Cuba: pooled OR =1.43, 95%CI: 1.00-2.04; Italy: pooled OR =0.61, 95%CI: 0.13-2.90. In random effects model, U.S: pooled OR=1.50, 95%CI: 1.25-1.80; China: pooled OR =4.67, 95%CI: 3.08-7.07; Cuba: pooled OR =1.43, 95%CI: 1.00-2.04; Italy: pooled OR =0.61, 95%CI: 0.13-2.90.CONCLUSIONS: the present meta-analysis provides the statistical evidence that the association between prostatitis and prostate cancer is significant. Public Library of Science 2013-12-31 /pmc/articles/PMC3877315/ /pubmed/24391995 http://dx.doi.org/10.1371/journal.pone.0085179 Text en © 2013 Jiang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Jiang, Junyi
Li, Jinyi
Yunxia, Zhang
Zhu, Hong
Liu, Junjiang
Pumill, Chris
The Role of Prostatitis in Prostate Cancer: Meta-Analysis
title The Role of Prostatitis in Prostate Cancer: Meta-Analysis
title_full The Role of Prostatitis in Prostate Cancer: Meta-Analysis
title_fullStr The Role of Prostatitis in Prostate Cancer: Meta-Analysis
title_full_unstemmed The Role of Prostatitis in Prostate Cancer: Meta-Analysis
title_short The Role of Prostatitis in Prostate Cancer: Meta-Analysis
title_sort role of prostatitis in prostate cancer: meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877315/
https://www.ncbi.nlm.nih.gov/pubmed/24391995
http://dx.doi.org/10.1371/journal.pone.0085179
work_keys_str_mv AT jiangjunyi theroleofprostatitisinprostatecancermetaanalysis
AT lijinyi theroleofprostatitisinprostatecancermetaanalysis
AT yunxiazhang theroleofprostatitisinprostatecancermetaanalysis
AT zhuhong theroleofprostatitisinprostatecancermetaanalysis
AT liujunjiang theroleofprostatitisinprostatecancermetaanalysis
AT pumillchris theroleofprostatitisinprostatecancermetaanalysis
AT jiangjunyi roleofprostatitisinprostatecancermetaanalysis
AT lijinyi roleofprostatitisinprostatecancermetaanalysis
AT yunxiazhang roleofprostatitisinprostatecancermetaanalysis
AT zhuhong roleofprostatitisinprostatecancermetaanalysis
AT liujunjiang roleofprostatitisinprostatecancermetaanalysis
AT pumillchris roleofprostatitisinprostatecancermetaanalysis